Navigation Links
Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2013 Sales And EPS Of $675 Million And $1.01, Respectively, Both Record Quarterly Highs. Reaffirms Full Year 2013 Diluted Adjusted EPS Outlook Of $4.10 To $4.20.
Date:4/25/2013

re information about Sigma-Aldrich, please visit the website at www.sigma-aldrich.com.

Non-GAAP Financial Measures:  The Company supplements its disclosures made in accordance with accounting principles generally accepted in the United States (U.S. GAAP) with certain non-GAAP financial measures.  The Company does not, and does not suggest investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, GAAP financial information.  These non-GAAP measures may not be consistent with the presentation by other companies inside or outside of the Company's industry.  Whenever the Company uses such non-GAAP measures, it provides a reconciliation of such measures to the most closely applicable GAAP measure.  See the Supplemental Financial Information on pages 10 and 11 for these reconciliations.

With over 60% of sales denominated in currencies other than the U.S. dollar, management uses currency adjusted sales growth when analyzing Company performance, and believes it is useful as well to investors to judge the Company's performance.  Organic sales growth data presented in this release excludes currency and acquisitions impacts.  The Company calculates the impact of changes in foreign currency exchange rates by multiplying current period activity by the difference between current period exchange rates and prior period exchange rates.  The result is the defined impact of "changes in foreign currency exchange rates."  While we are able to report past currency impacts, we are unable to estimate changes that may occur later in 2013 to applicable exchange rates.  Any significant changes in currency exchange rates would likely have a significant impact on reported growth rates due to the volume of sales denominated in foreign currencies.

Management also uses the following non-GAAP measures to judge its performance and ability to&
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Sigma-Aldrich Announces Q1 2013 Earnings Conference Call
2. Sigma-Aldrich Corporations Sigma Life Science Business to Distribute Worldwide Olink Biosciences Protein Interaction Analysis Technology
3. Sigma-Aldrich Reports Record Full Year 2012 Results. Reports Q4 2012 Diluted EPS Of $0.96. Q4 2012 Sales Increased 7%. Full Year 2012 Adjusted Diluted EPS Was $3.85. Expects Full Year 2013 Adjusted Diluted EPS To Increase To $4.10 - $4.20.
4. Sigma-Aldrich Aligns Into Three New Market-Focused Business Units
5. Sigma-Aldrich (NASDAQ: SIAL) Declares $0.20 Quarterly Dividend
6. Sigma-Aldrich Enhances Customer Focus in China - Unveils Dynamic New Website and Expands Product Offering Through Vetec Brand
7. Sigma-Aldrich Corporation To Present At Upcoming Investor Conferences
8. Sigma-Aldrich Accelerates Analytical Research and Extends Benefits of Fused-Core Particle Technology to All HPLC Users with the Launch of New Ascentis Express 5 Micron Particle by Supelco
9. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
10. Morgan & Morgan Announces Investigation of MAP Pharmaceuticals (NASDAQ: MAPP)
11. SHAREHOLDER ALERT: Morgan & Morgan announces an investigation of Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and whether senior management and the board of directors violated fiduciary duties owed to Vertex shareholders.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014 Apex Medical Corporation (Apex, TWSE: ... Area Care sectors, announces that it is appealing the judgment ... in Germany that found the headgear ... that it has initiated invalidity challenges against various ResMed patents ... counterattacking against trivial and junk patents. ResMed ...
(Date:7/29/2014)... SAN DIEGO , July 29, 2014 /PRNewswire/ ... of Nancy Thornberry to its board ... and franchise head, Diabetes and Endocrinology for Merck ... research, strategy and overall pipeline management in diabetes, ... scientist, initiated and co-led the program that resulted ...
(Date:7/29/2014)... July 29, 2014  Encision Inc. (OTCQB:ECIA), a medical ... stray electrosurgical burns in minimally invasive surgery, today announced ... June 30, 2014. The Company posted quarterly ... loss of $202 thousand, or $(0.02) per share. These ... a net loss of $311 thousand, or $(0.04) per ...
Breaking Medicine Technology:Apex Continues Fighting Against Patents to Free Up Competition 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 3Encision Reports First Quarter Fiscal Year 2015 Results 2Encision Reports First Quarter Fiscal Year 2015 Results 3Encision Reports First Quarter Fiscal Year 2015 Results 4
... CHENGDU, China , May 7 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical ... and sells modernized traditional Chinese medicine,("TCM") and branded generics based in ... call to discuss its fiscal 2010 third,quarter results at 9:00 a.m. ... , , ...
... Hill-Rom Holdings, Inc. (NYSE: HRC ) today announced its fiscal 2010 third quarter ... on May 6, 2010 , and is payable on June 30, 2010 , to ... , , ... , Hill-Rom is a leading ...
Cached Medicine Technology:Tianyin Pharmaceutical Co., Inc. to Host Third Fiscal Quarter 2010 Results Earnings Conference Call on Wednesday, May 12, 2010 at 9:00 a.m. ET 2Tianyin Pharmaceutical Co., Inc. to Host Third Fiscal Quarter 2010 Results Earnings Conference Call on Wednesday, May 12, 2010 at 9:00 a.m. ET 3
(Date:7/29/2014)... Mach7 Technologies, an award-winning provider of ... of an enhanced version of its Physician & ... & Patient Portal enables direct communication and collaboration ... a comprehensive view of their care history, including ... care records and intelligently delivers access to records ...
(Date:7/29/2014)... Jessup, PA (PRWEB) July 29, 2014 ... Business Process Outsourcing solutions for health plans in ... and Managed Medicaid markets recently held its annual ... Jessup, Pa. Under the conference theme, “Partners in ... convened management executives and operations leaders from TMG ...
(Date:7/29/2014)... assistant professors at the Virginia Tech Carilion Research ... Commonwealth Health Research Board to investigate hereditary breast ... approaches. , The board funds research intended to benefit ... project to study the mechanisms behind hereditary breast cancer ... often has a poor outcome, especially in Virginians compared ...
(Date:7/29/2014)... On Friday, the United States Senate ... of October 12-18, 2014, as "National Case Management Week" ... healthcare outcomes for patients. The resolution was introduced by ... with support by the Case Management Society of America ... management professionals for their contributions to healthcare. , “Case ...
(Date:7/29/2014)... 2014 “Approximately 18% of our population ... common chronic illnesses,” Western Washington Medical Group says in ... for those suffering from allergies to seek medical attention. ... care each year in the United States,” they continue. ... of life for themselves, rather than seeking the appropriate ...
Breaking Medicine News(10 mins):Health News:Mach7 Technologies’ Physician & Patient Portal Consolidates Patient Care Records across the Enterprise and Simplifies Image Sharing and Communication 2Health News:Mach7 Technologies’ Physician & Patient Portal Consolidates Patient Care Records across the Enterprise and Simplifies Image Sharing and Communication 3Health News:TMG Health Client Forum Explores Strategies for Success in the Post-Reform Market 2Health News:TMG Health Client Forum Explores Strategies for Success in the Post-Reform Market 3Health News:Scientists to study hereditary breast cancer to find BRCA1 treatment 2Health News:CMSA Supports National Case Management Week Resolution Introduced in US Senate 2Health News:Allergy Sufferers are Urged to Seek Medical Help in Recent Article by Western Washington Medical Group 2Health News:Allergy Sufferers are Urged to Seek Medical Help in Recent Article by Western Washington Medical Group 3
... 26 ( www.amdl.com ) China continues to show ... Inc. (NYSE Alternext US: ADL) Chairman and CEO Mr. ... of an internal economic forecast research report indicating China ... the world, eclipsing every other international market.Mr. MacLellan has ...
... NEW YORK, Jan. 26 The National Center on ... announced today that Bruce E. Mosler has been ... ) , Mosler, president and CEO of Cushman ... estate services firm and serves on its board of ...
... hard work and dedication to the highest quality of care ... ... 26, 2009 -- Sierra Tucson, a premier treatment center dedicated ... disorders, today announced the achievement of accreditation as a "Hospital" ...
... LOUIS, Jan. 26 KV Pharmaceutical,(NYSE: KVa/KVb) has voluntarily suspended ... certain products that it distributes but does,not manufacture. The ... Additionally, the company will conduct a voluntary recall of ... recall are currently under discussion,with the U.S. Food and Drug ...
... Mass., Jan. 26 Instrumentation Laboratory (IL) today ... its contract to offer IL,s critical care portfolio ... history between the two companies, whose original contract ... of critical care analyzers, reagents, consumables and service, ...
... Medimetriks Pharmaceuticals announced today that the Company has ... PRGO ), a leading manufacturer in the ... Distributor of generic versions of Medimetriks, branded products in ... receive a percentage of Perrigo,s Net Sales on the ...
Cached Medicine News:Health News:AMDL, Inc. Chairman & CEO Announces Expert Opinion on China's Economic Forecast 2Health News:Bruce E. Mosler, President and CEO of Cushman & Wakefield Elected to CASA* Board 2Health News:Bruce E. Mosler, President and CEO of Cushman & Wakefield Elected to CASA* Board 3Health News:Sierra Tucson Achieves Hospital Accreditation, Now Holds Dual Accreditation by the Joint Commission 2Health News:KV Pharmaceutical Suspends Product Manufacturing, Shipping 2Health News:KV Pharmaceutical Suspends Product Manufacturing, Shipping 3Health News:KV Pharmaceutical Suspends Product Manufacturing, Shipping 4Health News:KV Pharmaceutical Suspends Product Manufacturing, Shipping 5Health News:Instrumentation Laboratory Wins Extended Agreement With MedAssets Supply Chain Systems for Critical Care Portfolio 2Health News:Instrumentation Laboratory Wins Extended Agreement With MedAssets Supply Chain Systems for Critical Care Portfolio 3Health News:Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals 2Health News:Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals 3
... Used for catheter or instrument ... features a fabrication process that eliminates ... and introducer dilator, facilitating introduction through ... reinforcement sleeve prevents movement between introducer ...
... Used for temporary internal ... junction to the bladder. ... packages. Intended for one-time ... is advised; C-Flex® and ...
... or instrument introduction. The dual knobs ... away and removed. The maximum diameter ... be introduced should be measured to ... Supplied sterile in peel-open packages. Intended ...
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: